DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis

Oncogenesis

Volumn 4, Issue 3, 2015, Pages

  Zhao, F ^a   Wang, M ^a   Li, S ^a   Bai, X ^a   Bi, H ^a   Liu, Y ^a   Ao, X ^a   Jia, Z ^a   Wu, H ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DACHSHUND HOMOLOGUE 1; PROTEIN; PROTEIN SNAI1; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; E BOX ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

EID: 84990898410     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2015.3     Document Type: Article

References (55)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580-584.
3. Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med 2013; 19: 1438-1449.
4. Serrano I, McDonald PC, Lock FE, Dedhar S. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFbeta-1-induced epithelial-mesenchymal transition (EMT). Oncogene 2013; 32: 50-60.
5. Wang M, Zhao F, Li S, Chang AK, Jia Z, Chen Y et al. AIB1 cooperates with ERalpha to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation. PLoS One 2013; 8: e65556.
6. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
7. Yuan H, Kajiyama H, Ito S, Yoshikawa N, Hyodo T, Asano E et al. ALX1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of ovarian cancer cells. Cancer Res 2013; 73: 1581-1590.
8. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009; 19: 156-172.
9. Burgess DJ. Breast cancer: Circulating and dynamic EMT. Nat Rev Cancer 2013; 13: 148.
10. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-428.
11. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97-110.
12. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-196.
13. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
14. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654.
15. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15-33.
16. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-89.
17. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-1618.
18. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005; 24: 2375-2385.
19. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol cell 2001; 7: 1267-1278.
20. Wu Y, Zhou BP. Snail: more than EMT. Cell Adh Migr 2010; 4: 199-203.
21. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24: 306-319.
22. Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou PG et al. G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 2012; 122: 1469-1486.
23. Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG et al. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene 2013; 32: 1351-1362.
24. Peiro S, Escriva M, Puig I, Barbera MJ, Dave N, Herranz N et al. Snail1 transcriptional repressor binds to its own promoter and controls its expression. Nucleic Acids Res 2006; 34: 2077-2084.
25. Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F et al. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res 2011; 71: 1292-1301.
26. Joost S, Almada LL, Rohnalter V, Holz PS, Vrabel AM, Fernandez-Barrena MG et al. GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Res 2012; 72: 88-99.
27. Mardon G, Solomon NM, Rubin GM. dachshund encodes a nuclear protein required for normal eye and leg development in Drosophila. Development 1994; 120: 3473-3486.
28. Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C et al. The Dachshund gene in development and hormone-responsive tumorigenesis. Trends Endocrinol Metab 2010; 21: 41-49.
29. Chen K, Wu K, Gormley M, Ertel A, Wang J, Zhang W et al. Acetylation of the Cell-Fate Factor Dachshund Determines p53 Binding and Signaling Modules in Breast Cancer. Oncotarget 2013; 4: 923-935.
30. Watanabe A, Ogiwara H, Ehata S, Mukasa A, Ishikawa S, Maeda D et al. Homozygously deleted gene DACH1 regulates tumor-initiating activity of glioma cells. Proc Natl Acad Sci USA 2011; 108: 12384-12389.
31. Wu K, Li A, Rao M, Liu M, Dailey V, Yang Y et al. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth. Mol Cell Biol 2006; 26: 7116-7129.
32. Nan F, Lu Q, Zhou J, Cheng L, Popov VM, Wei S et al. Altered expression of DACH1 and cyclin D1 in endometrial cancer. Cancer Biol Ther 2009; 8: 1534-1539.
33. Wu K, Katiyar S, Witkiewicz A, Li A, McCue P, Song LN et al. The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth. Cancer Res 2009; 69: 3347-3355.
34. Chen K, Wu K, Cai S, Zhang W, Zhou J, Wang J et al. Dachshund binds p53 to block the growth of lung adenocarcinoma cells. Cancer Res 2013; 73: 3262-3274.
35. Lee JW, Kim HS, Hwang J, Kim YH, Lim GY, Sohn WJ et al. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPalpha and GATA-1 in myeloid leukemia with MLL-AF9. Biochem Biophys Res Commun 2012; 426: 299-305.
36. Wu K, Yang Y, Wang C, Davoli MA, D'Amico M, Li A et al. DACH1 inhibits transforming growth factor-beta signaling through binding Smad4. J Biol Chem 2003; 278: 51673-51684.
37. Li X, Oghi KA, Zhang J, Krones A, Bush KT, Glass CK et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003; 426: 247-254.
38. Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM et al. Dachshund inhibits oncogeneinduced breast cancer cellular migration and invasion through suppression of interleukin-8. Proc Natl Acad Sci USA 2008; 105: 6924-6929.
39. Zhou J, Wang C, Wang Z, Dampier W, Wu K, Casimiro MC et al. Attenuation of Forkhead signaling by the retinal determination factor DACH1. Proc Natl Acad Sci USA 2010; 107: 6864-6869.
40. Wu K, Chen K, Wang C, Jiao X, Wang L, Zhou J et al. Cell Fate Factor DACH1 Represses YB-1-Mediated Oncogenic Transcription and Translation. Cancer Res 2014; 74: 829-839.
41. Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV et al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene 2012; 31: 4619-4629.
42. Shih JY, Yang PC. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011; 32: 1299-1304.
43. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008; 121: 727-735.
44. Vesuna F, van Diest P, Chen JH, Raman V. Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 2008; 367: 235-241.
45. Alexander NR, Tran NL, Rekapally H, Summers CE, Glackin C, Heimark RL. N-cadherin gene expression in prostate carcinoma is modulated by integrindependent nuclear translocation of Twist1. Cancer Res 2006; 66: 3365-3369.
46. Wu K, Liu M, Li A, Donninger H, Rao M, Jiao X et al. Cell fate determination factor DACH1 inhibits c-Jun-induced contact-independent growth. Mol Biol Cell 2007; 18: 755-767.
47. Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA et al. The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer Res 2009; 69: 5752-5760.
48. Wu H, Sun L, Zhang Y, Chen Y, Shi B, Li R et al. Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem 2006; 281: 21848-21856.
49. Li S, Wang M, Ao X, Chang AK, Yang C, Zhao F et al. CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-alpha. Oncogene 2013; 32: 4883-4891.
50. Wu H, Chen Y, Liang J, Shi B, Wu G, Zhang Y et al. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature 2005; 438: 981-987.
51. Lee JW, Kim HS, Kim S, Hwang J, Kim YH, Lim GY et al. DACH1 regulates cell cycle progression of myeloid cells through the control of cyclin D, Cdk 4/6 and p21Cip1. Biochem Biophys Res Commun 2012; 420: 91-95.
52. Bi H, Li S, Wang M, Jia Z, Chang AK, Pang P et al. SUMOylation of GPS2 protein regulates its transcription-suppressing function. Mol Biol Cell 2014; 25: 2499-2508.
53. Xiao L, Chang AK, Zang MX, Bi H, Li S, Wang M et al. Induction of the CLOCK gene by E2-ERalpha signaling promotes the proliferation of breast cancer cells. PLoS One 2014; 9: e95878.
54. Hong Y, Xing X, Li S, Bi H, Yang C, Zhao F et al. SUMOylation of DEC1 protein regulates its transcriptional activity and enhances its stability. PLoS One 2011; 6: e23046.
55. Yang C, Li S, Wang M, Chang AK, Liu Y, Zhao F et al. PTEN suppresses the oncogenic function of AIB1 through decreasing its protein stability via mechanism involving Fbw7 alpha. Mol Cancer 2013; 12: 21.